Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nikolaos Trikalinos
Yale University Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
Active, not recruiting
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
Active, not recruiting - Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
Jennifer B. ValerinRecruiting - Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
Jennifer B. ValerinRecruiting - Memorial Hospital East
Shiloh, Illinois, United States
Nikolaos TrikalinosRecruiting - Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
Nikolaos TrikalinosRecruiting - Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
Nikolaos TrikalinosRecruiting - Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
Nikolaos TrikalinosRecruiting - Siteman Cancer Center-South County
St Louis, Missouri, United States
Nikolaos TrikalinosRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Nikolaos TrikalinosRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Aug 2024
- Primary completion
- 14 Dec 2026
- Completion
- 14 Dec 2026
- Last update posted
- 13 May 2026
- Registered enrollment
- 24
- Registry id
- NCT05687123
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.